Prothena Corporation plc (PRTA) Estados Financieros e Histórico

Prothena Corporation plc (PRTA) — Precio $8.24 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Prothena Corporation plc (PRTA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Prothena Corporation plc registró ingresos de $9.7M en el último ejercicio fiscal, con un CAGR de 5 años del 62.6%.

Márgenes de los últimos 12 meses: margen bruto 43.5%, margen operativo -115.1%, margen neto -80.7%.

Al precio actual de $8.24, PRTA presenta beneficios negativos (P/E no significativo) y un ROE del -14.98%. La capitalización bursátil es de $431M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$1.1M$27.5M$955000$814000$853000$200.6M$53.9M$91.4M$135.2M$9.7M
Coste de Ventas$119.5M$134.5M$101.2M$50.8M$74.9M0000$3.7M
Beneficio Bruto-$118.5M-$107.0M-$100.2M-$50.0M-$74.0M$200.6M$53.9M$91.4M$135.2M$6.0M
I+D$119.5M$134.5M$101.2M$50.8M$75.1M$82.3M$135.6M$220.6M$222.5M$134.9M
Generales y Administrativos$41.1M$48.2M$42.5M$35.7M$38.7M$46.3M$49.9M$61.8M$67.2M$59.4M
Gastos Operativos$160.6M$182.8M$143.7M$35.7M$38.7M$128.6M$185.5M$282.4M$289.7M$190.5M
Beneficio Operativo-$159.5M-$155.3M-$158.9M-$85.7M-$112.7M$72.0M-$131.6M-$191.0M-$154.6M-$184.6M
EBITDA-$156.5M-$152.2M-$152.9M-$84.2M-$111.2M$73.0M-$124.9M-$159.6M-$128.0M-$197.1M
Gastos por Intereses$863000$3.7M$3.7M0000000
Beneficio Antes de Impuestos-$159.0M-$157.6M-$156.1M-$77.3M-$110.9M$71.9M-$125.6M-$160.5M-$128.9M-$200.8M
Impuestos$1.1M-$4.4M-$470000$379000$282999$4.9M-$8.7M-$13.5M-$6.6M$43.3M
Beneficio Neto-$160.1M-$153.2M-$155.6M-$77.7M-$111.1M$67.0M-$116.9M-$147.0M-$122.3M-$244.1M
BPA$-4.66$-4.07$-3.93$-1.95$-2.78$1.51$-2.47$-2.76$-2.27$-4.53
BPA Diluido$-4.66$-4.07$-3.93$-1.95$-2.78$1.38$-2.47$-2.76$-2.27$-4.53
Acciones en Circulación (Diluidas)$34.4M$37.7M$39.6M$39.9M$39.9M$48.5M$47.4M$53.2M$53.8M$53.8M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$2.4M$21000$51.1M$1.0M
Beneficio Bruto-$26.5M-$921000$50.2M$1.0M
Beneficio Operativo-$40.2M-$27.2M$25.8M-$21.1M
EBITDA-$35.9M-$20.6M$33.6M-$18.2M
Beneficio Neto-$36.5M-$21.6M$32.7M-$18.6M
BPA$-0.68$-0.40$0.61$-0.36
BPA Diluido$-0.68$-0.40$0.60$-0.36

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$386.9M$417.6M$427.7M$375.7M$295.4M$579.1M$710.4M$618.8M$471.4M$307.5M
Inversiones a Corto0000000000
Cuentas por Cobrar$178000$240000$2000$68000$15000$13000$62000$5.2M00
Inventario-$178000-$24000000000000
Activos Corrientes$391.4M$426.3M$431.4M$378.4M$299.3M$584.8M$719.1M$639.3M$485.4M$315.2M
Inmovilizado Material$56.5M$55.0M$52.8M$27.1M$20.4M$14.1M$8.0M$16.0M$13.8M$10.3M
Fondo de Comercio0000000000
Activos Intangibles0000000000
Activos Totales$460.0M$496.3M$498.8M$419.3M$333.0M$609.4M$758.0M$696.4M$547.1M$326.8M
Cuentas por Pagar$13.1M$13.6M$1.5M$1.2M$4.1M$3.7M$9.3M$25.4M$7.8M$5.9M
Deuda a Corto000000000$2.9M
Pasivos Corrientes$41.1M$37.4M$14.9M$17.7M$25.8M$33.5M$50.1M$56.9M$48.5M$40.8M
Deuda a Largo000000000$5.5M
Pasivos Totales$94.6M$89.1M$175.8M$146.3M$149.0M$143.3M$136.0M$135.0M$60.2M$46.3M
Reservas-$289.2M-$442.4M-$598.0M-$671.9M-$783.0M-$716.1M-$833.0M-$980.0M-$1.10B-$1.35B
Patrimonio Neto$365.4M$407.2M$323.0M$272.9M$184.0M$466.0M$622.0M$561.4M$486.9M$280.5M
Deuda Total$51.3M$52.2M$51.5M$22.9M$17.8M$12.3M$6.5M$11.8M$10.8M$13.9M
Deuda Neta-$335.6M-$365.4M-$376.1M-$352.8M-$277.5M-$566.8M-$703.9M-$607.0M-$460.5M-$293.7M
Capital Circulante$350.3M$389.0M$416.5M$360.7M$273.4M$551.4M$669.0M$582.4M$436.9M$274.4M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$330.8M$307.5M$329.5M$288.2M
Activos Totales$352.6M$326.8M$349.9M$302.6M
Pasivos Totales$57.6M$46.3M$37.3M$15.7M
Patrimonio Neto$295.0M$280.5M$312.6M$286.9M
Deuda Total$9.1M$13.9M$7.7M$7.0M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$160.1M-$153.2M-$155.6M-$77.7M-$111.1M$67.0M-$116.9M-$147.0M-$122.3M-$244.1M
Amortizaciones$2.4M$3.1M$3.2M$6.8M$1.5M$1.1M$744000$928000$893000$895000
Compensación en Acciones$24.9M$26.8M$27.0M$23.6M$22.0M$24.7M$31.3M$40.9M$46.0M$37.6M
Cambio en Capital Circulante$18.9M-$7.2M$94.5M-$4.4M$3.5M-$10.4M-$18.8M-$20.5M-$67.9M-$4.2M
Flujo de Caja Operativo-$117.3M-$131.2M-$28.3M-$53.0M-$80.4M$92.6M-$108.8M-$133.9M-$150.1M-$163.6M
Inversiones (CapEx)-$16.6M-$3.6M-$1.8M-$555000-$196000-$575000-$464000-$2.8M-$298000-$138000
Adquisiciones0$105000$390000000000
Recompra de Acciones00000000-$3530000
Dividendos Pagados0000000000
Flujo de Caja Libre-$133.9M-$134.8M-$30.0M-$53.5M-$80.6M$92.0M-$109.3M-$136.7M-$150.3M-$163.7M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$40.6M-$23.3M$28.9M-$25.0M
Inversiones (CapEx)-$1000000-$652000
Flujo de Caja Libre-$40.6M-$23.3M$28.9M-$25.7M
Dividendos Pagados0000
Compensación en Acciones$7.2M$7.1M$6.9M$7.9M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+2508.4%-96.5%-14.8%+4.8%+23414.3%-73.1%+69.5%+47.9%-92.8%
Crecimiento Beneficio Neto (anual)+4.3%-1.6%+50.1%-43.1%+160.3%-274.6%-25.7%+16.8%-99.6%
Crecimiento BPA (anual)+12.7%+3.4%+50.4%-42.6%+154.3%-263.6%-11.7%+17.8%-99.6%
Cambio en Acciones (anual)+9.6%+5.1%+0.8%+0.1%+21.4%-2.3%+12.3%+1.0%+0.1%
Crecimiento FCF (anual)-0.7%+77.7%-78.2%-50.5%+214.2%-218.7%-25.1%-10.0%-8.9%
Margen Bruto-11230.2%-388.9%-10495.1%-6145.2%-8678.9%100.0%100.0%100.0%100.0%61.8%
Margen Operativo-15121.8%-564.2%-16634.0%-10527.9%-13216.2%35.9%-244.1%-209.1%-114.4%-1905.8%
Margen EBITDA-14837.6%-553.0%-16010.4%-10343.2%-13038.7%36.4%-231.6%-174.6%-94.7%-2035.6%
Margen Neto-15176.1%-556.8%-16297.9%-9542.6%-13029.8%33.4%-217.0%-160.9%-90.5%-2520.6%
Margen FCF-12693.2%-489.9%-3146.0%-6575.4%-9444.1%45.9%-202.7%-149.6%-111.2%-1690.6%
Tasa Impositiva Efectiva-0.7%2.8%0.3%-0.5%-0.3%6.9%6.9%8.4%5.1%-21.5%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-3.90$-3.58$-0.76$-1.34$-2.02$1.90$-2.31$-2.57$-2.80$-3.04
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$34.4M$37.7M$39.6M$39.9M$39.9M$44.2M$47.4M$53.2M$53.8M$53.8M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-14.98%
Rentabilidad sobre capital invertido-21.36%
Rentabilidad sobre activos-14.54%
Margen bruto43.52%
Margen operativo-115.09%
Margen neto-80.67%

Salud financiera

Deuda / Patrimonio0.02
Ratio corriente25.05
Piotroski F-Score1
Altman Z-Score0.06

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-10.56-9.21-2.62-8.12-4.3232.72-24.39-13.17-6.10-2.11
P/VC4.623.471.262.312.614.694.593.441.531.83
P/V1601.6451.30426.66775.59561.9910.8952.9421.175.5153.08
Margen Bruto-11230.2%-388.9%-10495.1%-6145.2%-8678.9%100.0%100.0%100.0%100.0%61.8%
Margen Operativo-15121.8%-564.2%-16634.0%-10527.9%-13216.2%35.9%-244.1%-209.1%-114.4%-1905.8%
Margen Neto-15176.1%-556.8%-16297.9%-9542.6%-13029.8%33.4%-217.0%-160.9%-90.5%-2520.6%

Empresas relacionadas: BCYC · CRVS · FDMT · GOSS · KALV · NMRA · OLMA

Explorar sector: Healthcare · Biotechnology

Más secciones de PRTA: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones